Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1991
05/22/1991CN1012644B Process for preparation of flavanone derivatives
05/22/1991CN1012642B Process for preparation of sulfamoylbenzoic acid derivatives
05/22/1991CA2069404A1 Use of optically pure s(-) atenolol for the treatment of cardiovascular disorders
05/22/1991CA2069112A1 Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors
05/22/1991CA2028530A1 Substituted pyrimidobenzimidazole derivatives
05/21/1991US5017704 2,6-imino-2,6,7-trideoxy-D-glycero-D-gluco heptitol
05/21/1991US5017703 Antiallergens, antiinflammatory
05/21/1991US5017701 Process for the preparation of purine derivatives
05/21/1991US5017700 Coenzyme
05/21/1991US5017619 Anitdiabetic
05/21/1991US5017616 Isoleucine, leucine, valine
05/21/1991US5017613 Valproic acid preparations
05/21/1991US5017611 Ethyl-3-(2-ethyl-2,2-dimethylhydrazinium)-propionate salts to treat arrhythmia
05/21/1991US5017609 Storage stability, adrenergic blocking agents
05/21/1991US5017608 Hydrocinnamic acid derivatives
05/21/1991US5017607 Levodopa, methyl ester
05/21/1991US5017603 Xanthomegnin, a known compound, is an antiparasitic agent
05/21/1991US5017599 Antitumor, antiviral distamycin A analog
05/21/1991US5017596 Arylpyrazolylcarbinol compounds with analgesic activity
05/21/1991US5017590 1,4-dihydropyridine-threonine compounds with cardiovascular activity
05/21/1991US5017589 Novel amino acid derivatives
05/21/1991US5017588 Anticoagulants
05/21/1991US5017587 Treatment of plantar warts using cycloheximide
05/21/1991US5017586 5-dialkylaminomethyl-2-furanomethanol derivatives having anti-hypertensive properties
05/21/1991US5017583 Leukotriene antagonists
05/21/1991US5017580 Memory enhancing-R-N-(1-azabicyclo[2.2.2.]oct-3-yl)benzamides and thiobenzamides
05/21/1991US5017579 Use of aminoalkoxyphenyl derivatives for reducing and/or controlling excessive intraocular pressure
05/21/1991US5017578 N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents
05/21/1991US5017577 Using Purine Cinnamic Acids
05/21/1991US5017576 Antianxiolytic, hypnotic, anticonvulsant, antiepileptic
05/21/1991US5017575 Treatment of immunologically based disorders, specifically Crohn's disease
05/21/1991US5017574 Novel imidazobenzodiazepines
05/21/1991US5017573 Serotonin receptor antagonist
05/21/1991US5017572 Calcium antagonist
05/21/1991US5017571 Carbamic acid ester of substituted 7-hydroxy-2,3,4,5-tetrahydro-1H-3-benzazepines
05/21/1991US5017570 Dibenzoxazepine compounds useful in the treatment of cerebral vasospasm or its sequela
05/21/1991US5017569 Cephalosporin derivatives
05/21/1991US5017566 Redox systems for brain-targeted drug delivery
05/21/1991US5017564 Solid pharmaceutical preparation and method of producing same
05/21/1991US5017382 Polyoxyethylene glycol crosslinked, prostaglandin
05/21/1991US5017380 Storage stability
05/21/1991US5017378 Intraorgan injection of biologically active compounds contained in slow-release microcapsules or microspheres
05/21/1991US5017370 Improved method of performing angioplasty procedures
05/21/1991US5017366 Sunscreen, erythromycin
05/21/1991US5016652 Dermally Applicable Patch
05/21/1991CA2030340A1 Agroclavine and elymoclavine derivatives, process for their production and their use in pharmaceutical agents
05/21/1991CA2030240A1 Diazine derivatives
05/21/1991CA2030238A1 Heterocyclic compounds, method for preparing thereof, and medications comprising them
05/21/1991CA2029748A1 Alkoxymethylidene epipodophyllotoxin glucosides
05/21/1991CA2029421A1 Pharmaceutical compositions and methods for inhibition of maillard's reaction
05/21/1991CA2027863A1 Anti-inflammatory furanone compounds
05/21/1991CA1284336C Amido substituted naphthalenes and intermediates thereof
05/21/1991CA1284333C ANTIHYPERCHOLESTEROLEMIC .beta.-LACTONES
05/21/1991CA1284332C N-[4-o-hydroxyphenyl-1,3-dioxan-5-yl-hexenoyl]sulphonamides
05/21/1991CA1284331C N-¬4-o-hydroxyphenyl-1,3-dioxan-5-yl-hexenoyl|sulphonamides
05/21/1991CA1284330C 2,4-diphenyl-1,3-dioxanes
05/21/1991CA1284329C [(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1h-fluoren-7-yl) oxy] ethanimidamides and [(2,3,9,9a-tetrahydro-3-oxo-9a- substituted-1h-fluoren-7-yl) oxy]-ethanimidic acid hydrazides,their derivatives and their salts
05/21/1991CA1284326C Tricyclic compounds
05/21/1991CA1284325C Antipsychotic cyclic imide derivatives of 2-(4- butylpiperazin-1-yl) pyridines
05/21/1991CA1284324C Carbapenem process
05/21/1991CA1284322C 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-3,4- dihydro-5h-2,3-benzodiazepine and a process for preparing same
05/21/1991CA1284320C 2-substituted-1,3-propylidenediphosphonate derivatives, and the process for their preparation
05/21/1991CA1284318C 18-phenyloestrane derivatives
05/21/1991CA1284295C Anticalculus oral composition containing phosphonoformic acid
05/20/1991CA2014637A1 Treatment of infertility
05/18/1991WO1991007417A1 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses
05/18/1991WO1991007378A1 Cycloalkyl-substituted glutaramide diuretic agents
05/18/1991CA2067197A1 Cycloalkyl-substituted glutaramide diuretic agents
05/18/1991CA2030209A1 Therapeutic agents
05/18/1991CA2030177A1 Indole derivatives
05/18/1991CA2030140A1 Medicament preparations containing a metal salt of ibuprofen and process for preparing same
05/18/1991CA2030133A1 Pyridazine derivatives, process for their preparation and pharmaceutical compositions containing them
05/17/1991WO1991007176A1 Method and composition for treating inflammatory bowel disorders
05/17/1991CA2030105A1 Acat inhibitors
05/17/1991CA2030004A1 Tetrahydronaphthalene derivatives and preparation thereof
05/17/1991CA2029647A1 Osmotic, oral dosage form for fertility control
05/17/1991CA2003274A1 Treatment of colic and teething
05/16/1991WO1991006629A1 Oligonucleotide analogs with novel linkages
05/16/1991WO1991006566A1 Novel compounds
05/16/1991WO1991006556A1 2' modified oligonucleotides
05/16/1991WO1991006549A1 Cephalosporin compounds and production thereof
05/16/1991WO1991006548A1 Inhibitors of purine nucleoside phosphorylase
05/16/1991WO1991006540A1 1,4-bis(alkylamino)-2,3-diaza-anthracene-9,10-diones
05/16/1991WO1991006527A1 Substituted aminoalkylbenzene derivative and medicine containing the same
05/16/1991WO1991006301A1 L-alpha-glycerophosphoryl-d-myo-inositol for the treatment of peripheral neuropathies and of cerebropathies
05/16/1991WO1991006299A1 Method for the treatment of an opportunistic infection
05/16/1991WO1991006298A1 New use of condensed quinoline compound
05/16/1991WO1991006295A1 Analgesic composition containing optically pure s(+) flurbiprofen
05/16/1991WO1991006294A1 Phosphate binders for oral prescriptions
05/16/1991WO1991006293A2 Composition containing 2,3-butanedione monoxime and method for reversibly arresting muscle activity
05/16/1991WO1991006284A1 Pharmaceutical preparations
05/16/1991WO1991006283A1 Tissue moisturizing composition and method
05/16/1991DE4035456A1 Pharmaceutical composition
05/16/1991DE4035442A1 Medicament contg. r- or s- alpha-lipoic acid
05/16/1991DE4035226A1 Use of medicament containing muscarine agonist - to prevent and treat ventricular arrhythmia, especially acute or malignant arrhythmia
05/16/1991CA2067755A1 L-alpha-glycerophosphoryl-d-myo-inositol for the treatment of peripheral neuropathies and of cerebropathies
05/16/1991CA2029940A1 Use of new injectable biodegradable microspheres, process for preparation thereof and injectable suspension comprising them
05/16/1991CA2029934A1 Cholesterol ester hydrolase inhibitors
05/16/1991CA2003177A1 Treatment of skin diseases with artemisinin and derivatives
05/15/1991EP0427694A1 Synthesis of mannojirimycin derivatives
1 ... 7348 7349 7350 7351 7352 7353 7354 7355 7356 7357 7358 7359 7360 7361 7362 7363 7364 7365 7366 7367 7368 ... 7860